∆8-THC, THC-O Acetates and CBD-di-O Acetate: Emerging Synthetic Cannabinoids Found in Commercially Sold Plant Material and Gummy Edibles
- PMID: 35674405
- PMCID: PMC9564187
- DOI: 10.1093/jat/bkac036
∆8-THC, THC-O Acetates and CBD-di-O Acetate: Emerging Synthetic Cannabinoids Found in Commercially Sold Plant Material and Gummy Edibles
Abstract
Presented is the analysis of four cannabinoid-based products. These products were part of a case involving visual and auditory hallucinations that precipitated the commission of a felony and subsequent arrest. The products were labeled to contain ∆8-tetrahydrocannabinol (∆8-THC) or THC acetate (THC-O-A). Primary reference materials were not available for ∆8-THC-O-A, ∆10-THC-O-A, cannabidiol di-acetate (CBD-di-O-A) or respective deuterated internal standards. THC-O-A and CBD-di-O-A standards were prepared by derivatizing ∆8-THC, ∆9-THC, ∆10-THC, CBD, ∆9-THC-d3 and CBD-d3 using acetic anhydride. The cannabinoid-based products were determined to contain ∆8-THC, ∆8-THC-O-A, ∆9-THC-O-A and CBD-di-O-A and/or other phytocannabinoids using three different analytical techniques. Direct analysis in real-time-time-of-flight mass spectrometry was used for identifying exact masses. A gas chromatograph-mass spectrometer was used for the identification of compounds and to quantitate THC-O-As in the products. A liquid chromatograph-tandem mass spectrometer was used to identify and quantitate phytocannabinoids and CBD-di-O-A in the products. To the authors' knowledge, this is the first case report involving the identification of THC-O-As and CBD-di-O-A in commercially available products. Minimal clinical/pharmacological data is available for these emerging synthetic cannabinoids/novel psychoactive substances.
© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures





Similar articles
-
Production of identical retention times and mass spectra for {delta}9-tetrahydrocannabinol and cannabidiol following derivatization with trifluoracetic anhydride with 1,1,1,3,3,3-hexafluoroisopropanol*.J Anal Toxicol. 2012 Jan-Feb;36(1):61-5. doi: 10.1093/jat/bkr017. J Anal Toxicol. 2012. PMID: 22290754
-
A validated method for the simultaneous quantification of cannabidiol, Δ9 -tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open-label trial.Drug Test Anal. 2021 Mar;13(3):614-627. doi: 10.1002/dta.2947. Epub 2020 Dec 1. Drug Test Anal. 2021. PMID: 33095968 Clinical Trial.
-
Comprehensive cannabinoid profiling of acid-treated CBD samples and Δ8-THC-infused edibles.Food Chem. 2024 May 15;440:138187. doi: 10.1016/j.foodchem.2023.138187. Epub 2023 Dec 14. Food Chem. 2024. PMID: 38134831
-
Cannabidiol-Derived Cannabinoids: The Unregulated Designer Drug Market Following the 2018 Farm Bill.Med Cannabis Cannabinoids. 2024 Feb 13;7(1):10-18. doi: 10.1159/000536339. eCollection 2024 Jan-Dec. Med Cannabis Cannabinoids. 2024. PMID: 38352661 Free PMC article. Review.
-
Phytocannabinoids - An Overview of the Analytical Methodologies for Detection and Quantification of Therapeutically and Recreationally Relevant Cannabis Compounds.Crit Rev Anal Chem. 2023;53(1):211-231. doi: 10.1080/10408347.2021.1949694. Epub 2021 Jul 30. Crit Rev Anal Chem. 2023. PMID: 34328047 Review.
Cited by
-
Delta-8 Tetrahydrocannabinol Exposures Reported to US Poison Centers: Variations Among US States and Regions and Associations with Public Policy.J Med Toxicol. 2024 Oct;20(4):389-400. doi: 10.1007/s13181-024-01030-z. Epub 2024 Aug 21. J Med Toxicol. 2024. PMID: 39168936 Free PMC article.
-
An emerging trend in Novel Psychoactive Substances (NPSs): designer THC.J Cannabis Res. 2024 May 3;6(1):21. doi: 10.1186/s42238-024-00226-y. J Cannabis Res. 2024. PMID: 38702834 Free PMC article. Review.
-
Human metabolism of the semi-synthetic cannabinoids hexahydrocannabinol, hexahydrocannabiphorol and their acetates using hepatocytes and urine samples.Drug Test Anal. 2025 Mar;17(3):372-386. doi: 10.1002/dta.3740. Epub 2024 May 28. Drug Test Anal. 2025. PMID: 38804224 Free PMC article.
-
Commercial Delta-8 THC Products: an Analysis of Content and Labeling.J Med Toxicol. 2024 Jan;20(1):31-38. doi: 10.1007/s13181-023-00974-y. Epub 2023 Nov 2. J Med Toxicol. 2024. PMID: 37917314 Free PMC article.
-
Biotechnological potential of Cannabis sativa adventitious roots for producing immunomodulatory and anti-inflammatory bioactive compounds.Sci Rep. 2025 Aug 22;15(1):30904. doi: 10.1038/s41598-025-16130-1. Sci Rep. 2025. PMID: 40847038
References
-
- Thomsen R., Nielsen L.M., Holm N.B., Rasmussen H.B., Linnet K., Indices Consortium (2015) Synthetic cannabimimetic agents metabolized by carboxylesterases. Drug Testing and Analysis, 7, 565–576. - PubMed
-
- United States Centers for Disease Control and Prevention . (2018) Synthetic cannabinoids: What are they? What are their effects? https://www.cdc.gov/nceh/hsb/chemicals/sc/default.html (accessed Feb 3, 2022).
-
- National Institute on Drug Abuse . (2018) Synthetic Cannabinoids (K2/Spice) DrugFacts. https://nida.nih.gov/publications/drugfacts/synthetic-cannabinoids-k2spice (accessed Aug 4, 2021).
-
- European Monitoring Centre for Drugs and Drug Addiction . (2009) Understanding the ‘Spice’ Phenomenon. https://www.emcdda.europa.eu/publications/thematic-papers/understanding-... (accessed Feb 3, 2022).
-
- United States Drug Enforcement Administration . (2020) K2/Spice - Drug Fact Sheet. https://www.dea.gov/sites/default/files/2020-06/K2-spice-2020.pdf (accessed Aug 4, 2021).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials